Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (38)

• Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses via openalex
• Altered maturation and function of peritoneal macrophages: Possible role in pathogenesis of endometriosis via openalex
• Angiogenesis and Macrophage Activation in Endometriosis via openalex
• Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis via openalex
• Cytokine Regulation of Cellular Proliferation in Endometriosis via openalex
• Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. via openalex
• Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: a model for endometriosis? via openalex
• Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women via openalex
• Heritable aspects of endometriosis via openalex
• Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
• Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1  via openalex
• Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. via openalex
• Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. via openalex
• Localization in Tissues and Secretion of Eotaxin by Cells from Normal Endometrium and Endometriosis1 via openalex
• Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis via openalex
• Macrophage derived growth factors m odulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis via openalex
• Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells via openalex
• Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
• Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease via openalex
• Prevalence and genesis of endometriosis via openalex
• Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
• Role of Cytokines in Progression of Endometriosis via openalex
• The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue via openalex
• W2418200982 via openalex
• W1992042536 via openalex
• W4231513285 via openalex
• W1975879084 via openalex
• W1639924204 via openalex
• W2039144212 via openalex
• W1633340712 via openalex
• W2090197643 via openalex
• W2093303434 via openalex
• W2097467749 via openalex
• W2143715300 via openalex
• W2149913162 via openalex
• W2346020725 via openalex
• W2346708642 via openalex
• W2410335340 via openalex

Cited by (38)

• The role of peroxisome proliferator-activated receptors in endometriosis 2024
• Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions 2022
• Immunosuppression and immunotherapy in endometriosis 2021
• PPARγ Agonists: Emergent Therapy in Endometriosis 2021
• Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis 2021
• PPARγ induces the paroxysm of endometriosis by regulating the transcription of MAT2A gene. 2021
• Rosiglitazone affects the progression of surgically‑induced endometriosis in a rat model 2020
• New therapeutic approaches for endometriosis besides hormonal therapy 2019
• Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
• An Update on Pathophysiology and Medical Management of Endometriosis 2016
• Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-  by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions 2014
• Dinitrosyl iron complexes with glutathione suppress experimental endometriosis in rats 2014
• The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis 2014
• Regression of experimental endometriotic implants in a rat model with the angiotensin <scp>II</scp> receptor blocker losartan 2014
• Endometriosis 2013
• Literature Review on Biological Effects of against Gynaecological Diseases 2013
• Peroxisome proliferator-activated receptor γ agonist suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosis 2013
• PPARγ Activation Inhibits Growth and Survival of Human Endometriotic Cells by Suppressing Estrogen Biosynthesis and PGE2 Signaling. 2013
• Dinitrosyl iron complexes with cysteine suppress the development of experimental endometriosis in rats 2012
• New trends for the medical treatment of endometriosis 2012
• Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
• Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis 2012
• The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis 2011
• Association of Peroxisome Proliferator‐Activated Receptor‐Gamma 2 Pro12Ala Polymorphism with Advanced‐Stage Endometriosis 2010
• Molecular profiling of human endometrium and endometriosis 2010
• PPAR–gamma: a dagger in endometriosis 2010
• Thiazolidinediones as Therapy for Endometriosis: A Case Series 2009
• Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion 2009
• Endometriosis 2009
• New drugs in development for the treatment of endometriosis 2008
• Emerging drugs for endometriosis 2008
• Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells 2008
• Peroxisome proliferator-activated receptor-γ ligand reduced tumor necrosis factor-α-induced interleukin-8 production and growth in endometriotic stromal cells 2007
• Peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model 2007
• Metformin Suppresses Interleukin (IL)-1β-Induced IL-8 Production, Aromatase Activation, and Proliferation of Endometriotic Stromal Cells 2007
• Angiogenesis and antiangiogenic therapy in endometriosis 2007
• Nuclear Factor-κB (NF-κB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large? 2006
• Emerging drugs in endometriosis 2006

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:15:23.967219+00:00

unpaywall

last seen: 2026-06-02T02:00:03.124865+00:00